Talaris Therapeutics
Louisville, US · Delaware corporation · 4 known investors
Founders & leadership
SI
Suzanne IldstadFounder
SR
Scott RequadtExecutive
GM
Geoff MackayNamed on SEC filing
FN
Francois NaderNamed on SEC filing
Board
SA
MM
NG
Nick GalakatosBoard director
Investors · 4
Reported raises · per SEC filings
Form D private placements$115M disclosed across 1 round · 2020
▶$115MraisedOct 2020 · 24 investors · BiotechnologyRule 506(b)
▶$115MraisedOct 2020 · 24 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Sandip AgarwalaDirector
- Scott RequadtExecutive Officer, Director
- Geoff MackayDirector
- Francois NaderDirector
- Mark McDadeDirector
- Nick GalakatosDirector
- Suzanne IldstadExecutive Officer, Director
- Offering amount
- $115M
- Amount sold
- $115M
- First sale
- Sep 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who founded Talaris Therapeutics?
- Talaris Therapeutics was founded by Suzanne Ildstad.
- Who are Talaris Therapeutics's investors?
- Talaris Therapeutics's investors include Citadel, Invus, Qiming Healthcare, Viking Global Investors.
- How much funding has Talaris Therapeutics raised?
- Talaris Therapeutics has disclosed $115M raised across 1 round.
- Where is Talaris Therapeutics headquartered?
- Talaris Therapeutics is headquartered in Louisville, US.